Pharma Industry News

Puma Biotech breast cancer drug likely approved in Europe after reexamination

A committee of the European Medicines Agency is likely to approve the drug, five months after regulators recommended against approvalOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]